Method for treating neurogenic inflammation pain with botulinum toxin and substance P components
AssigneeAllergan, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating neurogenic inflammation pain. The methods include administering an effective amount of a composition which includes a botulinum toxin component and a substance P component to a patient, thereby treating the neurogenic inflammation pain.
Claims14
A method for treating neurogenic inflammation pain, the method comprises injecting a therapeutically effective amount of about 0.01 units to about 1,000 units of an agent to a patient, the agent comprising the light chain of a botulinum toxin covalently coupled to the HN portion of the heavy chain of the botulinum toxin, and a substance P component covalently coupled to the botulinum toxin HN portion, the substance P component being effective in binding to a substance P receptor, thereby treating the neurogenic inflammation pain for at least about two months.
Dependencies are inferred from the claim text.